T. Rowe Price Investment Management, Inc. Elanco Animal Health Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Elanco Animal Health Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 19,554,942 shares of ELAN stock, worth $360 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
19,554,942
Previous 15,983,391
22.35%
Holding current value
$360 Million
Previous $168 Million
66.39%
% of portfolio
0.18%
Previous 0.11%
Shares
8 transactions
Others Institutions Holding ELAN
# of Institutions
418Shares Held
487MCall Options Held
868KPut Options Held
1.42M-
Dodge & Cox San Francisco, CA82.9MShares$1.53 Billion0.71% of portfolio
-
Primecap Management CO Pasadena, CA51.8MShares$954 Million0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA47.8MShares$881 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$429 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX22.7MShares$419 Million0.08% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $8.74B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...